NEW RESEARCH: 12-page Quarterly Update on Aeterna Zentaris (AEZS-NASDAQ)

Posted by Laura Swartz

July 27, 2015 at 11:28 AM

We published a 12-page Quarterly Update on specialty biopharmaceutical company Aeterna Zentaris, Inc. this morning. The report updates readers on Aeterna's news, milestones, and clinical and commercial development status since the publication of our base report, the Executive Informational Overview from April 2015.

Read More

Topics: AEZS

Receive Our Research Notifications

About This Blog

We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.

Posts by Topic